Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects.
Li JJ, Liu HH, Wu NQ, Yeo KK, Tan K, Ako J, Krittayaphong R, Tan RS, Aylward PE, Baek SH, Dalal J, Fong AYY, Li YH, O'Brien RC, Lim TSE, Koh SYN, Scherer DJ, Tada H, Kang V, Butters J, Nicholls SJ. Li JJ, et al. Among authors: ako j. Expert Opin Drug Metab Toxicol. 2020 Sep;16(9):837-851. doi: 10.1080/17425255.2020.1802426. Epub 2020 Aug 11. Expert Opin Drug Metab Toxicol. 2020. PMID: 32729743 Review.
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Schwartz GG, et al. N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7. N Engl J Med. 2018. PMID: 30403574 Free article. Clinical Trial.
Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Tan JWC, Sim D, Ako J, Almahmeed W, Cooper ME, Dalal JJ, Deerochanawong C, Huang DWC, Johar S, Kaul U, Kim SG, Koh N, Kong AP, Krittayaphong R, Kwok B, Matawaran BJ, Nguyen QN, Ong LM, Park JJ, Peng Y, Quek DK, Suastika K, Sukor N, Teo BW, Teoh CK, Zhang J, Reyes EB, Goh SY. Tan JWC, et al. Among authors: ako j. Eur Cardiol. 2021 Apr 19;16:e14. doi: 10.15420/ecr.2020.52. eCollection 2021 Feb. Eur Cardiol. 2021. PMID: 33976709 Free PMC article. Review.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators. Schwartz GG, et al. J Am Coll Cardiol. 2021 Aug 3;78(5):421-433. doi: 10.1016/j.jacc.2021.04.102. J Am Coll Cardiol. 2021. PMID: 34325831 Free PMC article. Clinical Trial.
Tackling cardiometabolic risk in the Asia Pacific region.
Li JJ, Yeo KK, Tan K, Ako J, Krittayaphong R, Tan RS, Aylward PE, Lam CP, Baek SH, Dalal J, Fong A, Li YH, O'Brien RC, Koh SYN, Scherer DJ, Tada H, Kang V, Butters J, Nicholls SJ. Li JJ, et al. Among authors: ako j. Am J Prev Cardiol. 2020 Nov 8;4:100096. doi: 10.1016/j.ajpc.2020.100096. eCollection 2020 Dec. Am J Prev Cardiol. 2020. PMID: 34327472 Free PMC article. Review.
2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations.
Tan JWC, Chew DP, Tsui KL, Tan D, Duplyakov D, Hammoudeh A, Zhang B, Li Y, Xu K, Ong PJ, Firman D, Gamra H, Almahmeed W, Dalal J, Tam LW, Steg G, Nguyen QN, Ako J, Al Suwaidi J, Chan M, Sobhy M, Shehab A, Buddhari W, Wang Z, Fong AYY, Karadag B, Kim BK, Baber U, Chin CT, Han YL. Tan JWC, et al. Among authors: ako j. Eur Cardiol. 2021 Nov 8;16:e43. doi: 10.15420/ecr.2021.35. eCollection 2021 Feb. Eur Cardiol. 2021. PMID: 34815751 Free PMC article. Review.
Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease.
Hashimoto T, Minami Y, Asakura K, Katamine M, Kato A, Katsura A, Sato T, Muramatsu Y, Kameda R, Meguro K, Shimohama T, Ako J. Hashimoto T, et al. Among authors: ako j. J Clin Lipidol. 2022 Jan-Feb;16(1):104-111. doi: 10.1016/j.jacl.2021.11.012. Epub 2021 Dec 4. J Clin Lipidol. 2022. PMID: 34924352
Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia.
Koh N, Ference BA, Nicholls SJ, Navar AM, Chew DP, Kostner K, He B, Tse HF, Dalal J, Santoso A, Ako J, Tada H, Park JJ, Ong ML, Lim E, Subramaniam T, Li YH, Phrommintikul A, Iyengar SS, Ray S, Park KW, Tan HC, Chunhamaneewat N, Yeo KK, Tan JWC. Koh N, et al. Among authors: ako j. Eur Cardiol. 2021 Dec 9;16:e54. doi: 10.15420/ecr.2021.36. eCollection 2021 Feb. Eur Cardiol. 2021. PMID: 35024056 Free PMC article. Review.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
Ezetimibe enhances and stabilizes anticoagulant effect of warfarin.
Hashikata T, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Namba S, Kitasato L, Hashimoto T, Ishii S, Kameda R, Shimohama T, Tojo T, Ako J. Hashikata T, et al. Among authors: ako j. Heart Vessels. 2017 Jan;32(1):47-54. doi: 10.1007/s00380-016-0832-z. Epub 2016 Apr 6. Heart Vessels. 2017. PMID: 27052207
597 results